← Back to Clinical Trials
Recruiting EARLY_Phase 1 NCT06593405

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Age-Related Macular Degeneration
Sponsor MCPHS University
Study Type INTERVENTIONAL
Phase EARLY_Phase 1
Enrollment 50
Sex ALL
Min Age 50 Years
Max Age 100 Years
Start Date 2025-04-22
Completion 2026-12-05
Interventions
occupational therapy interventions for low vision care

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are: Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task? Participants will: Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

Eligibility Criteria

Inclusion Criteria: * Clients with AMD, DR or Glaucoma * Clients who choose to participate will allow their deidentified data to be evaluated for outcomes. Exclusion Criteria: * Clients with other age related eye diseases other than AMD, DR or Glaucoma. * Clients who do not wish to participate in this study.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}